PharmGKB summary: methotrexate pathway.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pharmacogenetics & Genomics

• Publication date

  2011-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/FPC.0b013e328343dd93PMID 21317831PMCID PMC3139712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response.

  2011cited by this paper
• Polymorphisms C677T and A1298C in the MTHFR gene in Mexican patients with rheumatoid arthritis treated with methotrexate: implication with elevation of transaminases

  2011cited by this paper
• The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number.

  2010cited by this paper
• Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis.

  2010influential reference
• 677TT Genotype Is Associated with Elevated Risk of Methotrexate (MTX) Toxicity in Juvenile Idiopathic Arthritis: Treatment Outcome, Erythrocyte Concentrations of MTX and Folates, and MTHFR Polymorphisms

  2010cited by this paper
• Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia

  2010cited by this paper
• Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate

  2010influential reference
• GENETIC POLYMORPHISMS IN KEY METHOTREXATE (MTX) PATHWAY GENES ASSOCIATED WITH RESPONSE TO MTX TREATMENT IN JUVENILE IDIOPATHIC ARTHRITIS

  2010cited by this paper
• Genome-wide Interrogation of Germline Genetic Variation Associated with Treatment Response in Childhood Acute Lymphoblastic Leukemia

  2010cited by this paper
• Associations between the genetic polymorphisms of MTHFR and outcomes of methotrexate treatment in rheumatoid arthritis.

  2010cited by this paper
• Folate Pathway Enzyme Gene Polymorphisms and the Efficacy and Toxicity of Methotrexate in Psoriatic Arthritis

  2010cited by this paper
• Transport of aminopterin by human organic anion transporters hOAT1 and hOAT3: Comparison with methotrexate.

  2010cited by this paper
• Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians

  2009cited by this paper
• DNA Variants in Region for Noncoding Interfering Transcript of Dihydrofolate Reductase Gene and Outcome in Childhood Acute Lymphoblastic Leukemia

  2009cited by this paper
• Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.

  2009cited by this paper
• Methotrexate Pharmacokinetics in Transgenic Mice with Liver-Specific Expression of Human Organic Anion-Transporting Polypeptide 1B1 (SLCO1B1)

  2009cited by this paper
• Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.

  2009cited by this paper
• Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.

  2009cited by this paper
• Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.

  2009cited by this paper
• Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia.

  2009influential reference
• Advances in individual prediction of methotrexate toxicity: a review

  2009cited by this paper
• Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis

  2009cited by this paper
• Treating childhood acute lymphoblastic leukemia without cranial irradiation.

  2009cited by this paper
• The critical role of alpha‐folate receptor in the resistance of melanoma to methotrexate

  2009cited by this paper
• Gene–gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritis

  2009influential reference
• Role of the glutamate 185 residue in proton translocation mediated by the proton-coupled folate transporter SLC46A1.

  2009cited by this paper
• Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate In vivo

  2009cited by this paper
• Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia.

  2009cited by this paper
• Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo

  2009cited by this paper
• Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms

  2009cited by this paper
• Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate.

  2009cited by this paper
• Impaired Clearance of Methotrexate in Organic Anion Transporter 3 (Slc22a8) Knockout Mice: A Gender Specific Impact of Reduced Folates

  2008cited by this paper
• In Vivo Response to Methotrexate Forecasts Outcome of Acute Lymphoblastic Leukemia and Has a Distinct Gene Expression Profile

  2008cited by this paper
• DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL.

  2008cited by this paper
• Increasing Systemic Exposure of Methotrexate by Active Efflux Mediated by Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3)

  2008cited by this paper
• Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.

  2008cited by this paper
• Pharmacogenomics of MRP Transporters (ABCC1-5) and BCRP (ABCG2)

  2008cited by this paper
• Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis.

  2008cited by this paper
• Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.

  2008cited by this paper
• Interaction of genes from influx-metabolism-efflux pathway and their influence on methotrexate efficacy in rheumatoid arthritis patients among Indians

  2008cited by this paper
• Influence of MTHFR and RFC1 Polymorphisms on Toxicities During Maintenance Chemotherapy for Childhood Acute Lymphoblastic Leukemia or Lymphoma

  2008cited by this paper
• Lack of association between HLA-G 14 bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis

  2008cited by this paper
• Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia

  2008cited by this paper
• Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX

  2008cited by this paper
• Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the In vivo Elimination of Methotrexate and its Main Toxic Metabolite 7-hydroxymethotrexate

  2008cited by this paper
• MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.

  2007cited by this paper
• Interaction of Nonsteroidal Anti-Inflammatory Drugs with Multidrug Resistance Protein (MRP) 2/ABCC2- and MRP4/ABCC4-Mediated Methotrexate Transport

  2007cited by this paper
• Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice

  2007cited by this paper
• Ancestry and pharmacogenetics of antileukemic drug toxicity.

  2007cited by this paper
• Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients.

  2007cited by this paper
• Acute Methotrexate-Induced Encephalopathy - Causal Relation to Homozygous Allelic State for MTR c.2756A>G (D919G)?

  2007cited by this paper
• Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis

  2007cited by this paper
• The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis

  2007cited by this paper
• Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia

  2007cited by this paper
• Therapeutic responses in childhood acute lymphoblastic leukemia (ALL) and haplotypes of gamma glutamyl hydrolase (GGH) gene.

  2007cited by this paper
• A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.

  2007influential reference
• Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival.

  2007cited by this paper
• 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.

  2007cited by this paper
• In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment

  2007cited by this paper
• Methylenetetrahydrofolate reductase and thymidylate synthase genotypes modify oral mucositis severity following hematopoietic stem cell transplantation

  2006influential reference
• Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma

  2006cited by this paper
• Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.

  2006cited by this paper
• Multidrug resistance proteins and folate supplementation: therapeutic implications for antifolates and other classes of drugs in cancer treatment

  2006cited by this paper
• Effects of Methylenetetrahydrofolate Reductase and Reduced Folate Carrier 1 Polymorphisms on High-Dose Methotrexate-Induced Toxicities in Children With Acute Lymphoblastic Leukemia or Lymphoma

  2006cited by this paper
• Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia.

  2006influential reference
• Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis

  2006cited by this paper
• High‐dose methotrexate in pediatric acute lymphoblastic leukemia: Impact of ABCC2 polymorphisms on plasma concentrations

  2006cited by this paper
• Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.

  2006influential reference
• MTHFR 677 (C→T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95

  2006cited by this paper
• HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis

  2006cited by this paper
• Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout Mice

  2006cited by this paper
• Epigenetic regulation of human gamma-glutamyl hydrolase activity in acute lymphoblastic leukemia cells.

  2006cited by this paper
• Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption.

  2006cited by this paper
• Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia.

  2006influential reference
• Interaction of Methotrexate with Organic-Anion Transporting Polypeptide 1A2 and Its Genetic Variants

  2006cited by this paper
• A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination

  2005cited by this paper
• Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics.

  2005cited by this paper
• Polymorphisms of genes controlling homocysteine levels and IQ score following the treatment for childhood ALL.

  2005cited by this paper
• Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.

  2005cited by this paper
• Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.

  2005cited by this paper
• Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia.

  2005cited by this paper
• No evidence of association of methylenetetrahydrofolate reductase polymorphism with occurrence of second neoplasms after treatment of childhood leukemia

  2005cited by this paper
• Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes

  2005cited by this paper
• Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1)

  2005cited by this paper
• Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis

  2005influential reference
• Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia

  2004cited by this paper
• Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.

  2004influential reference
• Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3.

  2004cited by this paper
• Methionine Synthase D919G Polymorphism, Folate Metabolism, and Colorectal Adenoma Risk

  2004cited by this paper
• Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.

  2004cited by this paper
• Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis.

  2004cited by this paper
• The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability.

  2004cited by this paper
• Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia.

  2004cited by this paper
• Methylenetetrahydrofolate Reductase Genotype Affects Risk of Relapse after Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia

  2004cited by this paper
• A substrate specific functional polymorphism of human gamma-glutamyl hydrolase alters catalytic activity and methotrexate polyglutamate accumulation in acute lymphoblastic leukaemia cells.

  2004cited by this paper
• High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma

  2004cited by this paper
• Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia

  2004cited by this paper
• Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis.

  2004cited by this paper
• Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia.

  2003cited by this paper
• The influence of cyclin D1 (CCND1) 870A>G polymorphism and CCND1-thymidylate synthase (TS) gene-gene interaction on the outcome of childhood acute lymphoblastic leukaemia.

  2003cited by this paper

• Association of ABCG2 Polymorphisms with Methotrexate Efficacy and Toxicity in Saudi Rheumatoid Arthritis Patients

  2025cites this paper
• Methotrexate gene polymorphisms link to toxicity but not pharmacokinetics in Chinese adults and adolescents with acute lymphoblastic leukemia.

  2025cites this paper
• Associations of Ferritin and Folate Status With Clinical Outcomes in Childhood Cancer Patients: A Prospective Cohort Study

  2025cites this paper
• Impact of Pharmacogenetics on High-Dose Methotrexate Toxicity in Pediatric Oncology

  2025cites this paper
• A high-throughput microphysiological system to quantify key events leading to liver fibrosis.

  2025cites this paper
• Association between ABCB1 C3435 T polymorphism- and methotrexate-related toxicity in pediatric acute lymphoblastic leukemia: a meta-analysis

  2025cites this paper
• The Role of miRNAs as Predictors of Acute Lymphoblastic Leukemia Chemotherapy Toxicity in Children: A Systematic Review

  2025cites this paper
• Pathway‐Informed Machine Learning Identifies Genetic Predictors of High‐Dose Methotrexate‐Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia

  2025cites this paper
• The Effect of Dextrose Hypotonic vs Saline Hydration on Methotrexate-Induced Nephrotoxicity in Male and Female Rats

  2024cites this paper
• Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis

  2024cites this paper
• Association between genetic variants of membrane transporters and the risk of high-grade hematologic adverse events in a cohort of Mexican children with B-cell acute lymphoblastic leukemia

  2024cites this paper
• Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate

  2024cites this paper
• Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol

  2024cites this paper
• Genetic polymorphisms and their association with methotrexate polyglutamates during maintenance treatment in Korean children and young adults with acute lymphoblastic leukemia.

  2024cites this paper
• Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury.

  2023cites this paper
• Metabolomic profiling reveals the mechanisms underlying the nephrotoxicity of methotrexate in children with acute lymphoblastic leukemia

  2023cites this paper
• Novel and replicated clinical and genetic risk factors for toxicity from high‐dose methotrexate in pediatric acute lymphoblastic leukemia

  2023cites this paper
• Efficacy and gastrointestinal tolerability of methotrexate in late-onset rheumatoid arthritis patients: a prospective cohort study

  2023cites this paper
• Nanotechnology Approaches for Prevention and Treatment of Chemotherapy-Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors.

  2023cites this paper
• Case report: Hepatotoxicity and nephrotoxicity induced by methotrexate in a paediatric patient, what is the role of precision medicine in 2023?

  2023influential citation
• External Evaluation of Population Pharmacokinetic Models for High‐Dose Methotrexate in Adult Patients with Hematological Tumors

  2023cites this paper
• Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia

  2023cites this paper
• A meta-analysis of the association between the ATIC 347 C/G polymorphism and methotrexate responsiveness and toxicity in rheumatoid arthritis.

  2023cites this paper
• Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review

  2023cites this paper
• Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia

  2023cites this paper
• Impact of Mercaptopurine Metabolites on Disease Outcome in the AIEOP‐BFM ALL 2009 Protocol for Acute Lymphoblastic Leukemia

  2023cites this paper
• The Role of Single Nucleotide Polymorphisms in Transporter Proteins and the Folate Metabolism Pathway in Delayed Methotrexate Excretion: A Case Report and Literature Review

  2022cites this paper
• Methotrexate-Induced Liver Injury Is Associated with Oxidative Stress, Impaired Mitochondrial Respiration, and Endoplasmic Reticulum Stress In Vitro

  2022cites this paper
• Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia

  2022cites this paper
• Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia

  2022cites this paper
• Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report

  2022cites this paper
• An empirical review on the risk factors, therapeutic strategies and materials at nanoscale for the treatment of oral malignancies

  2022cites this paper
• Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study

  2022cites this paper
• Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study

  2022cites this paper
• Correlation between serum methotrexate-polyglutamate 3 (MTX-PG3) level and disease activity in rheumatoid arthritis patients: A prospective cohort study

  2022cites this paper
• Evaluation of cytogenetic and molecular markers with MTX-mediated toxicity in pediatric acute lymphoblastic leukemia patients

  2022cites this paper
• Genetic basis of clinical variants of chemotherapy toxicity in children with acute lymphoblastic leukemia (literature review)

  2022cites this paper
• Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies

  2021cites this paper
• Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response

  2021cites this paper
• Plasma Distribution of Methotrexate and Its Polyglutamates in Pediatric Acute Lymphoblastic Leukemia: Preliminary Insights

  2021cites this paper
• Differentially expressed miRNAs in bone after methotrexate treatment

  2021cites this paper
• A Risk Scoring Model for High-Dose Methotrexate-Induced Liver Injury in Children With Acute Lymphoblastic Leukemia Based on Gene Polymorphism Study

  2021cites this paper
• Short-term systemic methotrexate administration in rats induces astrogliosis and microgliosis.

  2021cites this paper
• Genetic factors involved in delayed methotrexate elimination in children with acute lymphoblastic leukemia

  2021cites this paper
• Genetic markers that could influence clinical decision making during treatment with methotrexate.

  2020cites this paper
• Effects of germline variants in DHFR and FPGS on methotrexate metabolism and relapse of leukemia.

  2020cites this paper
• Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis

  2020cites this paper
• Simultaneous Determination of Urine Methotrexate, 7-Hydroxy Methotrexate, Deoxyaminopteroic Acid, and 7-Hydroxy Deoxyaminopteroic Acid by UHPLC-MS/MS in Patients Receiving High-dose Methotrexate Therapy

  2020cites this paper
• Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia

  2020cites this paper
• Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism

  2020cites this paper
• Protective Effects of Ginger extract against Methotrexate induced cytotoxicity in mice

  2020cites this paper
• Effect of SLCO1B1 Polymorphisms on High‐Dose Methotrexate Clearance in Children and Young Adults With Leukemia and Lymphoblastic Lymphoma

  2020cites this paper
• Compendium of Mechanistic Insights of Distinct Conventional Anticancer Therapies and Their Grievous Toxicities

  2020cites this paper
• Do intravenous fluid substitutions influence methotrexate clearance? An unanticipated impact of an intravenous sodium bicarbonate drug shortage

  2020cites this paper
• Clinical and Laboratory Associations with Methotrexate Metabolism Gene Polymorphisms in Rheumatoid Arthritis

  2020cites this paper
• A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis

  2020cites this paper
• The Role of ARID5B in Acute Lymphoblastic Leukemia and Beyond

  2020cites this paper
• Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy

  2020cites this paper
• Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities

  2020cites this paper
• Clinical implementation of pharmacogenetics and model‐informed precision dosing to improve patient care

  2020cites this paper
• Circadian clock-controlled drug metabolism and transport

  2020cites this paper
• Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics

  2020cites this paper
• Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology

  2020cites this paper
• Disease modifying drugs for rheumatological diseases: a brief history of everything.

  2020cites this paper
• Pharmacogenetic studies of thiopurine methyltransferase genotype-phenotype concordance and effect of methotrexate on thiopurine metabolism

  2020cites this paper
• Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity.

  2019cites this paper
• Population Pharmacokinetic Study and Individual Dose Adjustments of High‐Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia or Osteosarcoma

  2019cites this paper
• Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology

  2019cites this paper
• Plasma creatinine as predictor of delayed elimination of high‐dose methotrexate in childhood acute lymphoblastic leukemia: A Danish population‐based study

  2019cites this paper
• High-flux hemodialysis versus glucarpidase for methotrexate-associated acute kidney injury: What’s best?

  2019cites this paper
• Methotrexate Disposition in Pediatric Patients with Acute Lymphoblastic Leukemia: What Have We Learnt From the Genetic Variants of Drug Transporters.

  2019cites this paper
• Association between ABCB1 C3435T polymorphism and methotrexate treatment outcomes in rheumatoid arthritis patients: a meta-analysis.

  2019cites this paper
• The Circadian Clock Gene Bmal1 Controls Intestinal Exporter MRP2 and Drug Disposition

  2019cites this paper
• Membrane‐Spanning Protein Genetic Polymorphisms Related to Methotrexate Therapeutic Outcomes in a Chinese Rheumatoid Arthritis Population

  2019cites this paper
• The Effect of Methotrexate on the Pool of Low-Molecular Weight Sulfur-Containing Compounds in the Brain of Rats

  2019cites this paper
• Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study

  2019cites this paper
• Relación entre los polimorfismos genéticos relacionados con el transporte celular, poliglutamación y metabolismo del metotrexato y la respuesta terapéutica en artritis reumatoide

  2019cites this paper
• LC-MS metabolomics comparisons of cancer cell and macrophage responses to methotrexate and polymer-encapsulated methotrexate

  2019cites this paper
• Association of ABCC2 with levels and toxicity of methotrexate in Malaysian Childhood Acute Lymphoblastic Leukemia (ALL)

  2019influential citation
• Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models

  2018cites this paper
• Prediction of response to methotrexate in rheumatoid arthritis

  2018influential citation
• Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients

  2018cites this paper
• Mir-pharmacogenetics in childhood acute lymphoblastic leukemia treatment/mir-farmakogenetika haurtzaroko leuzemia linfoblastiko akutuaren tratamentuan. // mir-pharmacogenetics in childhood acute lymphoblastic leukemia treatment/mir-farmakogenetika haurtzaroko leuzemia linfoblastiko akutuaren tratame

  2018cites this paper
• Use of MTHFR C 677 T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia

  2018cites this paper
• Pharmacogenomics and variations in the risk of toxicity during the consolidation/maintenance phases of the treatment of pediatric B-cell leukemia patients from an admixed population in the Brazilian Amazon.

  2018cites this paper
• Simultaneous determination of plasma methotrexate and 7‐hydroxy methotrexate by UHPLC–MS/MS in patients receiving high‐dose methotrexate therapy

  2018cites this paper
• Pharmacokinetics of low‐dose methotrexate in healthy beagle dogs

  2018cites this paper
• The Pharmacogenetics of Immune-Modulating Therapy.

  2018cites this paper
• Identification of pathways associated with chemosensitivity through network embedding

  2017cites this paper
• The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment

  2017influential citation
• Genome-Wide Screen Reveals sec21 Mutants of Saccharomyces cerevisiae Are Methotrexate-Resistant

  2017cites this paper
• An LC-MS chemical derivatization method for the measurement of five different one-carbon states of cellular tetrahydrofolate

  2017cites this paper
• Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy

  2017cites this paper
• Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance

  2017cites this paper
• Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia

  2017influential citation
• Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcoma

  2017cites this paper
• Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review

  2017cites this paper
• Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Antileukemic Drugs

  2017cites this paper
• Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate

  2016cites this paper
• Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis

  2016cites this paper